Pharmaceuticals, Biotechnology and Life Sciences
Novartis has announced first-of-its-kind long-term data showing that Cosentyx (secukinumab) provided sustained improvements in nail and palmoplantar psoriasis out to…
N4 Pharma, a specialist pharmaceutical company which reformulates existing drugs and vaccines to improve their performance, welcomes the announcement of the…
Circassia Pharmaceuticals welcomes the publication of new clinical guidelines by the UK’s National Institute for Health and Care Excellence (NICE),…
Oxford Pharmascience has gotten pre-IND scientific advice from the US regulatory drugs and foods authority about the development programme requirements likely…
Sanofi said on Wednesday it would ask health authorities to update information provided to physicians and patients on its dengue…
TopiVert Pharma, a clinical-stage biotechnology company developing Narrow Spectrum Kinase Inhibitors (NSKIs) for chronic inflammatory gastrointestinal (GI) and ocular diseases,…
The European Medicines Agency has accepted a variation to the Marketing Authorisation Application (MAAv) for Tagrisso (osimertinib) from Astrazeneca.
OptiBiotix Health is planing assemble a General Meeting in which it would ask the shareholders a re-organisation to allow the company to make…
Swedish Orphan Biovitrum has received approval from Health Canada for an oral suspension formulation of Orfadin (nitisinone).
Novartis revealed positive results from the FLASH study on Monday. The study met the primary endpoint demonstrating that switching patients…